In March this year, the National Medical Insurance Bureau issued a notice requesting that, first, novel coronavirus antigen detection reagents and corresponding detection items should be temporarily included in the basic medical insurance service directory of this province according to procedures. The relevant expenses incurred by the insured in the designated primary medical institutions shall be paid according to the current regulations of the overall planning area, and the expenses for purchasing testing reagents in designated retail pharmacies may be paid by personal accounts; Second, timely adjust the COVID-19 treatment drugs included in the scope of medical insurance payment.
Half a year later, 343 kinds of drugs, such as the first oral drug in COVID-19, officially passed the formal examination, and were included in the list of declared drugs for national basic medical insurance, industrial injury insurance and maternity insurance in 2022.
With the implementation of "Class B Management" of infection in novel coronavirus, can COVID-19 drugs and hospitalization expenses previously included in medical insurance be reimbursed? In response to the new epidemic, Anhui, Fujian Jinjiang and other places have made clear the proportion of medical insurance reimbursement in COVID-19, and Beijing, Shaanxi and other places have temporarily included the new crown treatment drugs in the scope of medical insurance reimbursement.
Anhui: The reimbursement rate of outpatient expenses for infection in COVID-19 is 70%.
According to the news of Anhui Provincial Medical Insurance Bureau, on February 29th 10, Anhui Provincial Medical Insurance Bureau, Anhui Provincial Department of Finance and Anhui Provincial Health and Health Committee jointly issued an urgent notice on doing a good job in the outpatient treatment of novel coronavirus infection, clarifying that the medical expenses incurred by the insured in the general outpatient (emergency) treatment in the co-ordination area that meet the requirements of COVID-19's pneumonia diagnosis and treatment plan should be included in the payment scope of the basic medical insurance co-ordination fund, and there is no deductible, reimbursement limit and reimbursement ratio.
Designated medical institutions that have opened the settlement service of the basic medical insurance fund as a whole are temporarily included in the overall settlement scope of COVID-19 infection outpatient service; The medical category of "COVID-19 Outpatient Service (1 102)" was unified to settle the outpatient expenses of COVID-19 infection.
Please click to enter the picture description (maximum 18 words).